Seiya Sato

ORCID: 0000-0002-5058-9189 · 6 papers in corpus
other 2023
Cancer science ·doi:10.1111/cas.15767

Recent studies reported the presence of oncogenic mutations in normal endometrial glands, but the biological significance remains unclear. The present study investigated the status of KRAS/PIK3CA driver mutations in normal endometrial gland…

other 2022
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol29050294

Ovarian seromucinous tumors (SMBTs) are relatively rare, and their carcinogenesis is largely unknown. In this study, the molecular features of SMBTs in Japan are assessed. DNA was extracted from microdissected paraffin-embedded sections fro…

observational 2022
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare10040694

Ovarian cancer has the highest mortality rate among all gynecological malignancies; therefore, a novel treatment strategy is needed urgently. Utilizing immune checkpoint inhibitors has been considered for microsatellite instability (MSI)-hi…

lab-animal 2021
Cancers ·doi:10.3390/cancers13133174

Endometriosis-harboring cancer-associated somatic mutations of PIK3CA and KRAS provides new opportunities for studying the multistep processes responsible for the functional and molecular changes in this disease. We aimed to establish a nov…

case-report 2021
Diseases (Basel, Switzerland) ·doi:10.3390/diseases9010014

Malignant transformation of extraovarian endometriosis is rare, with the carcinogenesis mechanism unclear. To clarify the actionable variants of rare-site endometriosis-associated cancer (RSEAC), we performed whole-exome sequencing for the …

review 2020
Cancer science ·doi:10.1111/cas.14571

The human endometrium is an essential component in human reproduction that has the unique characteristic of undergoing cyclic regeneration during each menstrual cycle. Vigorous regeneration after shedding may be sustained by stem/progenitor…